A detailed history of Golden State Equity Partners transactions in Karyopharm Therapeutics Inc. stock. As of the latest transaction made, Golden State Equity Partners holds 1,800 shares of KPTI stock, worth $1,404. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,800
Holding current value
$1,404
% of portfolio
0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$0.7 - $1.06 $1,260 - $1,908
1,800 New
1,800 $1,000
Q1 2023

Jun 01, 2023

SELL
$2.84 - $3.92 $118,854 - $164,052
-41,850 Closed
0 $0
Q1 2022

May 18, 2022

BUY
$5.91 - $14.38 $184,114 - $447,980
31,153 Added 291.23%
41,850 $308,000
Q1 2022

May 16, 2022

SELL
$5.91 - $14.38 $184,114 - $447,980
-31,153 Reduced 74.44%
10,697 $113,000
Q4 2021

Feb 11, 2022

BUY
$5.21 - $8.61 $61,983 - $102,433
11,897 Added 39.72%
41,850 $269,000
Q3 2021

Nov 15, 2021

BUY
$4.45 - $10.63 $34,932 - $83,445
7,850 Added 35.52%
29,953 $174,000
Q2 2021

Aug 12, 2021

BUY
$8.11 - $11.11 $92,502 - $126,720
11,406 Added 106.63%
22,103 $228,000
Q1 2021

May 13, 2021

BUY
$9.85 - $17.69 $105,365 - $189,229
10,697 New
10,697 $113,000

Others Institutions Holding KPTI

About Karyopharm Therapeutics Inc.


  • Ticker KPTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 79,806,600
  • Market Cap $62.2M
  • Description
  • Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...
More about KPTI
Track This Portfolio

Track Golden State Equity Partners Portfolio

Follow Golden State Equity Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Golden State Equity Partners, based on Form 13F filings with the SEC.

News

Stay updated on Golden State Equity Partners with notifications on news.